Freedom From Most Bothersome Headache-Associated Symptom Feasible as Primary End Point
Investigators examine most bothersome headache-associated symptoms as a feasible alternative to using 4 c-primary end points in acute migraine treatment trials.
Investigators examine most bothersome headache-associated symptoms as a feasible alternative to using 4 c-primary end points in acute migraine treatment trials.
Investigators assessed cognitive impairment using the Cambridge Neuropsychological Test Automated battery, administered on a touchscreen tablet.
Investigators examined whether chronic pain and hypoesthesia are linked in patients with MS.
The posterior cingulate cortex, precuneus, and thalamus were among the earliest regions to become atrophic in both relapse-onset phenotypes and primary-progressive multiple sclerosis.
No correlation was found between baseline 25-hydroxyvitamin D level and annualized relapse rates or time to first relapse.
Investigators developed a test of 10 timed instrumental activities of daily living to measure a broader range of functioning in MS.
Patients with more prominent white matter damage and serious cortical pathology may be at increased risk for converting to secondary progressive MS.
Cerebrospinal fluid immunoglobulin kappa to lambda ratio may be useful prognostic markers for early therapeutic stratification.
Investigators analyzed various calorie restricted diets and their effect on weight in patients with multiple sclerosis.
Ofatumumab was shown to suppress new brain MRI lesions in patients with relapsing forms of multiple sclerosis.